🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Recruitingn/aAges any - anyAllXuanwu Hospital, Beijing
NCT07620626 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

We designed the Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment (WEB-RWS), an ambidirectional, multicenter, post-market real-world study with a prospective active surveillance component. The study will include patients with IAs treated with commercially available WEB devices under the direction of treating physicians in routine clinical practice. Clinical, procedural, imaging, and safety data will be collected using a standardized electronic data capture system, with safety events adjudicated by an independent clinical events committee and imaging outcomes assessed by an independent core laboratory. The primary objective is to evaluate 12-month adequate aneurysm occlusion and major adverse events after WEB treatment. The study is expected to provide comprehensive post-market evidence on the real-world performance of the WEB device in China, including its safety,

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Retrospective Cohort: * Participants of any age and sex. * Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device. * Patients who completed at least one postoperative imaging follow-up. Prospective Cohort: * Participants of any age and sex. * Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device. * The participant, or legally authorized representative if applicable, understands the study requirements and procedures and provides written informed consent before any study-specific data collection. Exclusion Criteria: Retrospective Cohort: * Patients treated with a Woven EndoBridge device for whom intraoperative or postoperative follow-up imaging data are not available. * Patients considered by the investigator to be unsuitable for participation in this study. Prospective Cohort: * Participants who are currently participating in, or plan to participate during the follow-up period, another clinical study that may affect the results of this study. * Patients who are currently unable or expected to be unable to complete follow-up. * Patients with a life expectancy of less than 1 year due to other diseases or conditions. * Patients considered by the investigator to be unsuitable for participation in this study.
💊

What it tests

  • Intrasaccular Flow Disruption Device
📍

Where

1 site
Xuanwu Hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy